Because we also observed a similar NF-κB-inducing activity in some BMSCs derived from MCL patients and bortezomib-resistant activity is also prevalent in primary MCL samples [34], such a factor could also play a role in promoting MCL pathogenesis. Here, NFKB1 is linked to mantle cell lymphoma.